KVV E-Modules

Preformulation is best defined as:

A: Final stage of drug marketing B: Study of drug marketing strategies C: Characterization of physicochemical properties before formulation D: Clinical trial phase

The main purpose of preformulation studies is to:

A: Increase drug cost B: Delay product launch C: Minimize problems in later development stages D: Replace clinical trials

Which of the following is NOT a principle area of preformulation?

A: Physicochemical characterization B: Bulk characterization C: Clinical trial design D: Stability studies

Preformulation data is crucial for:

A: Marketing approval only B: Quality by Design (QbD) C: Packaging design only D: Advertising strategy

Ritonavir case study highlights:

A: Importance of packaging B: Drug pricing issues C: Polymorphism and its impact on formulation D: Clinical trial failures

Which regulatory submissions require preformulation data?

A: Only NDA B: IND, NDA, ANDA C: Only ANDA D: Only IND

Preformulation studies should ideally be conducted:

A: After marketing B: During clinical trials C: Before formulation development D: After product launch

Which factor must be known before starting preformulation?

A: Advertising budget B: Drug physicochemical properties C: Sales forecast D: Competitor branding

Emerging trend in preformulation includes:

A: Manual calculations only B: AI and machine learning C: Elimination of stability studies D: Avoidance of modeling

Preformulation helps in:

A: Choosing incorrect excipients B: Reducing development cost C: Increasing trial failures D: Delaying approval